2019
DOI: 10.1080/10406638.2019.1614640
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis, Characterization and In Vitro Antibacterial Evaluation of Novel 4-(1-(Pyrimidin-4-yl)Ethyl)-12H-Pyrimido[4′,5′:5,6][1,4]Thiazino[2,3-b]Quinoxaline Derivatives

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 28 publications
0
3
0
Order By: Relevance
“…A series of seven compounds were synthesized and characterized which were then subjected to in vitro antibacterial activity against a panel of 11 Gram‐positive and 10 Gram‐negative bacteria. Results were demonstrated as inhibition zone diameter, MIC and MBC wherein compounds 112 a and 112 b were the most potent compounds having significant activities against nine and six bacteria, respectively with MIC values ranging between 51–204 μg/mL as compared to standards, ceftriaxone, penicillin, cefazolin [62] …”
Section: Pharmacological Activities Of Quinoxaline‐based Compoundsmentioning
confidence: 99%
See 1 more Smart Citation
“…A series of seven compounds were synthesized and characterized which were then subjected to in vitro antibacterial activity against a panel of 11 Gram‐positive and 10 Gram‐negative bacteria. Results were demonstrated as inhibition zone diameter, MIC and MBC wherein compounds 112 a and 112 b were the most potent compounds having significant activities against nine and six bacteria, respectively with MIC values ranging between 51–204 μg/mL as compared to standards, ceftriaxone, penicillin, cefazolin [62] …”
Section: Pharmacological Activities Of Quinoxaline‐based Compoundsmentioning
confidence: 99%
“…Results were demonstrated as inhibition zone diameter, MIC and MBC wherein compounds 112 a and 112 b were the most potent compounds having significant activities against nine and six bacteria, respectively with MIC values ranging between 51-204 μg/mL as compared to standards, ceftriaxone, penicillin, cefazolin. [62] A series of quinoxaline derivatives were designed and synthesized by Dewangan et al as antimicrobial agents (113, Figure 32). All the synthesized compounds were assayed for in vitro antibacterial activity against the gram-positive bacteria [S. aureus (MTCC 96) and S. pyogenes (MTCC 442)] and gramnegative bacteria [E. coli (MTCC 443) and P. aeruginosa (MTCC 424)].…”
Section: Antibacterial and Antifungal Activitiesmentioning
confidence: 99%
“…tidepressant [23], anthelmintic [24], analgesic [25][26][27][28][29][30][31], anti-inflammatory [11,[32][33][34][35][36], antiviral [37][38][39][40][41][42][43], antifungal [44][45][46][47][48][49], antimalarial [50][51][52][53][54][55], antibacterial [56][57][58][59][60][61][62][63], antioxidant [14,[64][65], antithrombotic [66,67] and antiprotozoal [54,68]. Different quinoxaline-based drugs have been playing a main role in the therapy and treatment of various diseases, such as varenicline 4 (aids in smoking cessation), brimonidine 5 (an...…”
Section: Introductionmentioning
confidence: 99%